1,3-Benzodioxolyl-N-methylpentanamine

MBDP
Clinical data
Other names	1,3-Benzodioxolyl-N-methylpentanamine; N-Methyl-1,3-benzodioxolylpentanamine; MBDP; 3,4-Methylenedioxy-α-propyl-N-methylphenethylamine; Methyl-K; UWA-091; UWA091
Routes of; administration	Oral
ATC code	None;
Pharmacokinetic data
Duration of action	Unknown
Identifiers
	IUPAC name 1-(2H-1,3-benzodioxol-5-yl)-N-methylpentan-2-amine;
CAS Number	952016-78-3 ;
PubChem CID	17757316;
ChemSpider	21106348;
UNII	4D904VI4GR;
CompTox Dashboard (EPA)	DTXSID60590851 ;
Chemical and physical data
Formula	C13H19NO2
Molar mass	221.300 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C1=C2C(=CC=C1CC(NC)CCC)OCO2;
	InChI InChI=1S/C13H19NO2/c1-3-4-11(14-2)7-10-5-6-12-13(8-10)16-9-15-12/h5-6,8,11,14H,3-4,7,9H2,1-2H3; Key:PZVRSDBLMSXDCX-UHFFFAOYSA-N;

MBDP, also known as N-methyl-1,3-benzodioxolylpentanamine, 3,4-methylenedioxy-α-propyl-N-methylphenethylamine, methyl-K, or UWA-091, is a psychoactive drug of the phenethylamine, phenylisobutylamine, and MDxx families.^[1]^[2]^[3] It is the N-methyl analogue of BDP (K).^[1]

Use and effects

In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists MBDP's minimum dose as 100 mg orally and its duration as unknown.^[1] The drug produced no effects at tested doses.^[1]

Chemistry

Synthesis

The chemical synthesis of MBDP has been described.^[1]

Society and culture

Legal status

United Kingdom

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.^[4]

References

^ ^a ^b ^c ^d ^e ^f ^g "Methyl-K". PiHKAL.
^ Shulgin A, Manning T, Daley P (2011). The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds. Vol. 1. Berkeley: Transform Press. ISBN 978-0-9630096-3-0.
^ Shulgin AT (2003). "Basic Pharmacology and Effects". In Laing RR (ed.). Hallucinogens: A Forensic Drug Handbook. Forensic Drug Handbook Series. Elsevier Science. pp. 67–137. ISBN 978-0-12-433951-4. Archived from the original on 13 July 2025.
^ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Archived from the original on 22 October 2017. Retrieved 12 March 2014.

External links

[PiHKAL-1] ^ ^a ^b ^c ^d ^e ^f ^g "Methyl-K". PiHKAL.

[Shulgin_2011-2] Shulgin A, Manning T, Daley P (2011). The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds. Vol. 1. Berkeley: Transform Press. ISBN 978-0-9630096-3-0.

[Shulgin_2003-3] Shulgin AT (2003). "Basic Pharmacology and Effects". In Laing RR (ed.). Hallucinogens: A Forensic Drug Handbook. Forensic Drug Handbook Series. Elsevier Science. pp. 67–137. ISBN 978-0-12-433951-4. Archived from the original on 13 July 2025.

[4] "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Archived from the original on 22 October 2017. Retrieved 12 March 2014.

[1]

[2]

[3]

[4]